Amortization of Intangible Assets in USD of Teladoc Health, Inc. from 2013 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Teladoc Health, Inc. quarterly/annual Amortization of Intangible Assets history and change rate from 2013 to Q3 2025.
  • Teladoc Health, Inc. Amortization of Intangible Assets for the quarter ending 30 Sep 2025 was $85.8M, a 1.32% decline year-over-year.
  • Teladoc Health, Inc. Amortization of Intangible Assets for the twelve months ending 30 Sep 2025 was $345M, a 7.08% decline year-over-year.
  • Teladoc Health, Inc. annual Amortization of Intangible Assets for 2024 was $363M, a 11.5% increase from 2023.
  • Teladoc Health, Inc. annual Amortization of Intangible Assets for 2023 was $326M, a 33.2% increase from 2022.
  • Teladoc Health, Inc. annual Amortization of Intangible Assets for 2022 was $245M, a 25.3% increase from 2021.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Change (%)
Amortization of Intangible Assets, Annual (USD)
Amortization of Intangible Assets, YoY Annual Change (%)

Teladoc Health, Inc. Quarterly Amortization of Intangible Assets (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $345M $85.8M -$1.15M -1.32% 01 Jul 2025 30 Sep 2025 10-Q 30 Oct 2025
Q2 2025 $346M $88.7M -$6.2M -6.53% 01 Apr 2025 30 Jun 2025 10-Q 30 Jul 2025
Q1 2025 $353M $84.3M -$10.8M -11.3% 01 Jan 2025 31 Mar 2025 10-Q 01 May 2025
Q4 2024 $363M $86.5M -$8.19M -8.64% 01 Oct 2024 31 Dec 2024 10-K 27 Feb 2025
Q3 2024 $372M $86.9M -$4.93M -5.37% 01 Jul 2024 30 Sep 2024 10-Q 30 Oct 2025
Q2 2024 $376M $94.9M +$22.4M +30.8% 01 Apr 2024 30 Jun 2024 10-Q 30 Jul 2025
Q1 2024 $354M $95.1M +$28.2M +42.2% 01 Jan 2024 31 Mar 2024 10-Q 01 May 2025
Q4 2023 $326M $94.7M +$12.1M +14.6% 01 Oct 2023 31 Dec 2023 10-K 27 Feb 2025
Q3 2023 $314M $91.8M +$43.2M +88.7% 01 Jul 2023 30 Sep 2023 10-Q 31 Oct 2024
Q2 2023 $271M $72.5M +$15.8M +27.9% 01 Apr 2023 30 Jun 2023 10-Q 01 Aug 2024
Q1 2023 $255M $66.9M +$10.3M +18.1% 01 Jan 2023 31 Mar 2023 10-Q 26 Apr 2024
Q4 2022 $245M $82.6M +$32.6M +65.3% 01 Oct 2022 31 Dec 2022 10-K 27 Feb 2025
Q3 2022 $212M $48.7M -$924K -1.86% 01 Jul 2022 30 Sep 2022 10-Q 27 Oct 2023
Q2 2022 $213M $56.7M +$7.6M +15.5% 01 Apr 2022 30 Jun 2022 10-Q 28 Jul 2023
Q1 2022 $205M $56.6M +$10M +21.5% 01 Jan 2022 31 Mar 2022 10-Q 02 May 2023
Q4 2021 $195M $50M +$14.9M +42.4% 01 Oct 2021 31 Dec 2021 10-K 23 Feb 2024
Q3 2021 $180M $49.6M +$37.9M +324% 01 Jul 2021 30 Sep 2021 10-Q 02 Nov 2022
Q2 2021 $143M $49.1M +$40.1M +446% 01 Apr 2021 30 Jun 2021 10-Q 03 Aug 2022
Q1 2021 $102M $46.6M +$37.7M +424% 01 Jan 2021 31 Mar 2021 10-Q 02 May 2022
Q4 2020 $64.7M $35.1M +$25.9M +282% 01 Oct 2020 31 Dec 2020 10-K 01 Mar 2023
Q3 2020 $38.8M $11.7M +$3M +34.5% 01 Jul 2020 30 Sep 2020 10-Q 01 Nov 2021
Q2 2020 $35.8M $9M $0 0% 01 Apr 2020 30 Jun 2020 10-Q 02 Aug 2021
Q1 2020 $35.8M $8.9M +$200K +2.3% 01 Jan 2020 31 Mar 2020 10-Q 03 May 2021
Q4 2019 $35.6M $9.2M +$600K +6.98% 01 Oct 2019 31 Dec 2019 10-K 28 Feb 2022
Q3 2019 $35M $8.7M -$200K -2.25% 01 Jul 2019 30 Sep 2019 10-Q 06 Nov 2020
Q2 2019 $35.2M $9M +$1.7M +23.3% 01 Apr 2019 30 Jun 2019 10-Q 29 Jul 2020
Q1 2019 $33.5M $8.7M +$2M +29.9% 01 Jan 2019 31 Mar 2019 10-Q 29 Apr 2020
Q4 2018 $31.5M $8.6M +$2.5M +41% 01 Oct 2018 31 Dec 2018 10-K 01 Mar 2021
Q3 2018 $29M $8.9M +$3.6M +67.9% 01 Jul 2018 30 Sep 2018 10-Q 30 Oct 2019
Q2 2018 $25.4M $7.3M +$5.3M +265% 01 Apr 2018 30 Jun 2018 10-Q 31 Jul 2019
Q1 2018 $20.1M $6.7M +$4.8M +253% 01 Jan 2018 31 Mar 2018 10-Q 30 Apr 2019
Q4 2017 $15.3M $6.1M +$4.1M +205% 01 Oct 2017 31 Dec 2017 10-K 26 Feb 2020
Q3 2017 $11.2M $5.3M +$3.3M +165% 01 Jul 2017 30 Sep 2017 10-Q 01 Nov 2018
Q2 2017 $7.9M $2M +$1M +100% 01 Apr 2017 30 Jun 2017 10-Q 01 Aug 2018
Q1 2017 $6.9M $1.9M +$800K +72.7% 01 Jan 2017 31 Mar 2017 10-Q 01 May 2018
Q4 2016 $6.1M $2M +$900K +81.8% 01 Oct 2016 31 Dec 2016 10-K 27 Feb 2019
Q3 2016 $5.2M $2M +$800K +66.7% 01 Jul 2016 30 Sep 2016 10-Q 01 Nov 2017
Q2 2016 $4.4M $1M +$300K +42.9% 01 Apr 2016 30 Jun 2016 10-Q 02 Aug 2017
Q1 2016 $4.1M $1.1M +$400K +57.1% 01 Jan 2016 31 Mar 2016 10-Q 08 May 2017
Q4 2015 $3.7M $1.1M 01 Oct 2015 31 Dec 2015 10-K 27 Feb 2018
Q3 2015 $1.2M +$600K +100% 01 Jul 2015 30 Sep 2015 10-Q 27 Oct 2016
Q2 2015 $700K +$200K +40% 01 Apr 2015 30 Jun 2015 10-Q 03 Aug 2016
Q1 2015 $700K 01 Jan 2015 31 Mar 2015 10-Q 10 May 2016
Q3 2014 $600K 01 Jul 2014 30 Sep 2014 10-Q 02 Nov 2015
Q2 2014 $500K 01 Apr 2014 30 Jun 2014 10-Q 12 Aug 2015

Teladoc Health, Inc. Annual Amortization of Intangible Assets (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $363M +$37.4M +11.5% 01 Jan 2024 31 Dec 2024 10-K 27 Feb 2025
2023 $326M +$81.3M +33.2% 01 Jan 2023 31 Dec 2023 10-K 27 Feb 2025
2022 $245M +$49.3M +25.3% 01 Jan 2022 31 Dec 2022 10-K 27 Feb 2025
2021 $195M +$131M +202% 01 Jan 2021 31 Dec 2021 10-K 23 Feb 2024
2020 $64.7M +$29.1M +81.7% 01 Jan 2020 31 Dec 2020 10-K 01 Mar 2023
2019 $35.6M +$4.1M +13% 01 Jan 2019 31 Dec 2019 10-K 28 Feb 2022
2018 $31.5M +$16.2M +106% 01 Jan 2018 31 Dec 2018 10-K 01 Mar 2021
2017 $15.3M +$9.2M +151% 01 Jan 2017 31 Dec 2017 10-K 26 Feb 2020
2016 $6.1M +$2.4M +64.9% 01 Jan 2016 31 Dec 2016 10-K 27 Feb 2019
2015 $3.7M +$1.7M +85% 01 Jan 2015 31 Dec 2015 10-K 27 Feb 2018
2014 $2M +$1.4M +233% 01 Jan 2014 31 Dec 2014 10-K 01 Mar 2017
2013 $600K 01 Jan 2013 31 Dec 2013 10-K 03 Mar 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.